Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125809411 | 12580941 | 1 | I | 20160712 | 20160721 | 20160721 | EXP | JP-HQ SPECIALTY-JP-2016INT000583 | INTERCHEM | ADACHI M, MITSUDO K, YAMAMOTO N, ET AL. CHEMORADIOTHERAPY FOR MAXILLARY SINUS ADENOID CYSTIC CARCINOMA USING SUPERSELECTIVE INTRA-ARTERIAL INFUSION VIA A SUPERFICIAL TEMPORAL ARTERY. HEAD NECK. 2013;35:E89-E93; DOI:10.1002/HED.21925 | 42.00 | YR | M | Y | 0.00000 | 20160721 | OT | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125809411 | 12580941 | 1 | PS | CISPLATIN. | CISPLATIN | 1 | Unknown | 5 MG/M2, DAILY (TOTAL 252 MG) | 18057 | 5 | MG/M**2 | ||||||||
| 125809411 | 12580941 | 2 | SS | DOCETAXEL. | DOCETAXEL | 1 | Unknown | 15 MG/M2, WEEKLY (TOTAL 151 MG) | 0 | 15 | MG/M**2 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125809411 | 12580941 | 1 | Nasal sinus cancer |
| 125809411 | 12580941 | 2 | Nasal sinus cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125809411 | 12580941 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125809411 | 12580941 | Dermatitis | |
| 125809411 | 12580941 | Neutropenia | |
| 125809411 | 12580941 | Stomatitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |